blood trans fuss ion
TRANSCRIPT
1
BLOOD TRANSFUSSION
PEDIATRIC HEMATO-ONCOLOGY DIVISION MEDICAL FACULTY
SUMATERA UTARA UNIVERSITY
2
• BLOOD: - THE BIGGEST ORGAN (GIGANTIC ORGAN)- BIOLOGICAL MULTIANTIGENIC MATERIAL- CIRCULATING IN CARDIOVASCULER SYSTEM- CONSISTS OF :
1. CORPUSCULAR COMPONENT :- RED BLOOD CELLS LIVING MATERIAL- WHITE BLOOD CELLS MULTI ANTIGENIC- PLATELETS
2. NON CORPUSCULAR COMPONENT:- PLASMA : FLUID, ELECTROLYTE, PROTEIN
(ALBUMIN, TRANSFERIN, 1 - GLOBULIN, 2- GLOBULIN, - GLOBULIN, IMUNOGLOBULIN, CLOTTING FACTORS )
3
• BLOOD TRANSFUSSION:
BLOOD TRANSFERING PROCESS FROM DONOR TO RECIPIENT ORGAN TRANSPLANTATION
CONSIDER OF:
- BENEFIT AND RISK ASPECT
- IMMUNOHEMATOLOGY OF TRANSFUSSION
- INFORMED CONSENT OBTAINED TO EVERY NON EMERGENT TRANSFUSION
• GAVE BLOOD SAVE LIFE• GLOBAL BLOOD SAFETY INITIATIVE WHO 1989: ANY
TRANSFUSION WHICH IS NOT INDICATED IS CONTRAINDICATED
4
• PRINCIPLE– EVERY BLOOD TRANSFUSSION CONSISTS OF
MINIMAL ANTIGEN VARIATION AND OPTIMAL DOSES BLOOD COMPONENTS TRANSFUSSION MORE
RATIONAL THAN WHOLE BLOOD
• THE GOAL OF TRANSFUSSION ACHIEVED IF :* GOOD MANUFACTURING PRACTICE:
DONOR SELECTION, RECORDED, BLOOD SAMPLING, STORED, COMPONENT PROCESSING INCLUDE QUALITY CONTAINT* GOOD HOSPITAL PRACTICE:
INDICATION , REQUESTED VOLUME, CARED, EVALUATE PATIENT BEFORE AND AFTER TRANSFUSSION
5
PRETRANSFUSSION TESTS
COOMBS TESTBLOOD GROUP
BLOOD TUBE CLEAR LABELS
6
• PROBLEMS BLOOD TRANSFUSSION:1. INDICATIONS2. CONTRAINDICATIONS3. DOSES4. BENEFIT5. SIDE EFFECTS
BLOOD COMPONENTS TRANSFUSSION :- FIRST IN 1960- FROM WHOLE BLOOD → SEPARATES: RED BLOOD CELLS, GRANULOCYTE, PLATELETS,
FRESH FROZEN PLASMA, CRYOPRECIPITATE, ALBUMIN
7
1. RED BLOOD CELL COMPONENTS- 640 Ag, CONSISTS OF 20 BLOOD GROUPS SYSTEM: ABO, CDE, MNS, P, LEWIS, KELL, DUFFY,
LUTHERAN, KIDD, DIEGO.- BLOOD GROUP SYSTEM : * ABO: BY LANDSTEINER (1901) A,B,AB,O
BASED ON SURFACE Ag OF ERYTROCYTE
GROUP GENOTYPE NATURAL Ab (SERUM) A A/A or A/O ANTI- B B B/B or B/O ANTI- A AB A/B - O O/O ANTI A & ANTI B
8
1. A. FRESH WHOLE BLOOD - DOSE: 6 x BW (kg) x Hb - USE <1 DAY
SEVERE BLEEDING CAUSED BY TRAUMA OR SURGERY
* RHESUS : - LANDSTEINER & WIENER (1940)- BASED ON: Ag D ON ERITROCYTE SURFACE - INDONESIA : 100% Rh +- SERUM: NATURAL ANTIBODY (-) FROM BIRTH
RED BLOOD CELLS COMPONENTS
9
1.B. PACKED RED CELL (PRC) - DOSE: 4 x BW (kg) x Hb
(Ht 3/2 OF WHOLE BLOOD (Ht 70-80%) - CHILD & INFANT: 10 ml/kgBB/DAY - 1 UNIT PRC : 225-350 ml WITH Ht 55-65%
DOSES OF PRCHb (g/dL) PRC EVERY 3-4 HOURS
7-10 10 ml/kgBB5-7 5 ml/kgBB
<5, HEART FAILURE(-) 3ml/kgBB<5, HEART FAILURE() 3ml/kgBB + FUROSEMIDE<5, HEART FAILURE(+) EXCHANGE TRANSFUSSION
10
1C. PACKED RED CELLS LOW PLATELETS
1D. WASHED RED CELLS– > 85% LEUCOCYTE ARE REMOVED, AS WELL AS
99% OF THE ORIGINAL PLASMA
1E. FROZEN WASHED PACKED RED CELLS
1F. IRRADIATION RED BLOOD CELLS
11
INDICATIONS FOR RED BLOOD CELLTRANSFUSION
PACKED RED BLOOD CELLS
1. INFANT LESS THAN 4 MONTHS OLD– Hb < 13 g/dl IN NEONATES < 24 HOURS– Hb < 13 g/dl AND SEVERE PULMONARY DISEASE,
CYANOTIC HEART DISEASE OR HEART FAILURE– ACUTE BLOOD LOSS > 10% OF TOTAL BLOOD VOL– PHLEBOTOMY LOSSES OF >5-10% OF TOTAL BLOOD
VOL– Hb < 8 g/dl IN STABLE NEWBORN
12
PACKED RED BLOOD CELLS
2. PATIENTS 4 MONTHS OF AGE– SIGNIFICANT PREOPERATIVE OR POST OPERATIVE
ANEMIA– ACUTE BLOOD LOSS WITH HYPOVOLEMIA
UNRESPONSIVE TO CRYSTALLOID OR COLLOID
3. CHRONIC CONGENITAL OR ACQUIRED ANEMIA UNRESPONSE TO MEDICAL THERAPY AND Hb < 8 g/dl AND SYMPTOM OF ANEMIA
4. CHRONIC TRANSFUSION THALASSEMIA, SICKLE CELL DISEASE
13
WHOLE BLOOD (SELDOM USED)
1. MASSIVE TRANSFUSION OR ACUTE BLOOD LOSS , USUALLY ASSOCIATED WITH TRAUMA
2. CARDIOVASCULAR BY PASS SURGERY
3. EXTRACORPOREAL MEMBRANE OXYGENATION
14
GUIDELINES PRC TRANSFUSION FOR ONCOLOGY PATIENT
1. STABLE, ASYMPTOMATIC CHILD WITH Hb < 7g/dl AND LOW RETICULOCYTE COUNT
2. SYMPTOMATIC ANEMIA AND Hb < 10 g/dl
3. Hb < 8 g/dl IN PATIENT BEGINNING INDUCTION OR INTENSIFICATION COURSE OF CHEMOTHERAPY
4. ACUTE BLOOD LOSS > 10% OF TOTAL BLOOD VOL, OR ONGOING LOSS AND Hb < 8 g/dl IN A CHILD UNABLE TO PRODUCE RED CELLS
5. Hb < 7g/DL PRIOR TO GENERAL ANESTHESIA
6. RECEIVING RADIATION THERAPY Hb > 10 g/dl
15
2. PLATELETS TRANSFUSSIONINDICATIONS1. PREMATURE OR SICK INFANTS
- STABLE INFANT WITH PLATELET COUNT < 50x109 /L
- DISTRESSED INFANT WITH PLATELET COUNT < 100x109 /L
2. CHILDREN- PLATELET COUNT < 10x109 /L , IF
FEBRILE, INFECTED OR BLEEDING- PLATELET COUNT < 50x109 /L WITH
ANTICIPATED INVASIVE PROCEDURE:- LUMBAR PUNCTURE- QUALITATIVE PLATELET DEFECT- SURGERY
16
3. ONCOLOGY– NON BLEEDING PATIENT WITH PLATELET COUNT <
10x109 /L– INDUCTION CHEMOTHERAPY– BRAIN TUMORS PLATELET COUNT MAINTAIN AT >
30x109 /L– LUMBAR PUNCTURE WITH PLATELET COUNT < 30-
50x109 /L– BLEEDING PATIENT WITH NORMAL COAGULATION
STUDIES, PLATELET COUNT < 50x109 /L– SURGICAL PROCEDURE WITH PLATELET COUNT <
100x109 /L– INTRAMUSCULAR INJECTION , PLATELET COUNT <
20x109 /L
17
DOSAGE• 1 UNIT PLATELET /10kg INCREASED PLATELET 40-
50X109/L• PHERESIS PLATELET HARVESTED FROM SINGLE
DONOR , CONTAIN > 30x109/L PLATELET, EQUAL TO 6-8 UNITS OF RANDOM PLATELET
• THE VOLUME IS 250-300 ml
18
- FROM LEUCOPHERESIS, FILTER NYLON- ABO / Rh COMPATIBLE, HLA MATCHED- GAVE AS SOON AS POSSIBLE BECAUSE
CIRCULATING HALF LIFE IS 6-10 HOURS , SLOW INFUSSION IN 2-4 HOURS
- 1 UNIT : 1,0x1010 CELLS, IN ADDITION TO OTHER LEUCOCYTES, PLATELETS, AND 20-50 ml RBC
- RESUSPENDED IN APPROXIMATELY 200-300 ml OF ANTICOAGULATED PLASMA
3. GRANULOCYTE TRANSFUSSION
19
INDICATIONS
1. NEONATAL BACTERIAL SEPSIS
2. BACTERIAL OR FUNGAL SEPSIS, CULTURE POSITIVE, UNRESPONSIVE TO ANTIMICROBIAL THERAPY, ANC< 100/μL
DOSAGE• 1 UNIT GRANULOCYTE ADMINISTEREDAT 150
ml/m2/HOUR• UNITS ARE GIVEN DAILY UNTIL ANC >100/μL AND THE
INFECTION IS RESOLVING
20
FVIII CONSENTRATEFIBRINOGEN
VWFF XIII
4. PLASMA AND PLASMA PRODUCTSWHOLE BLOOD PLASMAPHERESIS
FRESH PLASMA
FRESH FROZEN PLASMA
CRYOSUPERNATAN
ALBUMIN
CRYOPRECIPITATE
21
TYPE & INDICATION OF PLASMA PRODUCTS
1. FRESH FROZEN PLASMA
- DOSES: 15-20 ml/kgBW FFP IN 1 HOUR
- CONSISTS OF :- FACTORS II,V,VII,VIII,IX,X,XI- PROTEIN C, S AND ANTITHROMBIN III- ELECTROLYTES, ALBUMIN, IMMUNOGLOBULIN,
PROTEIN COMPLEMENT
- 1 BAG FFP : 200 UNITS F.VIII
- SHOULD NOT BE USED IF COAGULOPATHY CAN BE
CORRECTED WITH SPECIFIC TREATMENT : VIT K,
CRYOPRECIPITATE, FACTOR CONCENTRATE
22
2. CRYOPRECIPITATE•CONSISTS OF : FVIII, F.XIII, FIBRINOGEN, F.VON WILLEBRAND•DOSAGE : 1 U/ 6 kg BW
3. ALBUMIN
- HIPOPROTEINEMIA- EXCHANGE PLASMA PROTEIN FLAME BURN- EXCHANGE PLASMA VOLUME
INDICATION
23
INDICATIONSFRESH FROZEN PLASMA
1. BLEEDING/INVASIVE PROCEDURE WITH CLOTTING FACTOR DEFICIENCY
2. TREATMENT OF ANTITHROMBIN III, PROTEIN C&S DEFICIENCY, OR F.XI DEFICIENCY (HEMOPHILIA C)
3. BLEEDING DURING MASSIVE TRANSFUSION
CRYOPRECIPITATE
1. BLEEDING/INVASIVE PROCEDURE WITH F.VIII, F.XIII DEFICIENCY, VON WILLEBRAND DISEASE, HYPOFIBRINOGENEMIA
2. SUPPORTIVE TREATMENT OF DIC
24
TRANSFUSSION REACTION
1. ALLERGIC REACTION– URTICARIA, WHEEZING, ANGIOEDEMATOUS REACTIONS– ANAPHYLACTOID REACTION : DYSPNEA,
PULMONARY/LARYNGEAL EDEMA, BRONCHASPASM– TRANSFUSION RELATED ACUTE LUNG INJURY– TREATMENT : STOP TRANSFUSION, ANTIHISTAMINE,
CORTICOSTEROID, EPINEPHRINE.
2. FEBRILE NON HEMOLYTIC REACTIONS– FEVER, CHILLS DURING TRANSFUSION– TREATMENT : STOP TRANSFUSION, EVALUATE VITAL SIGN AND
BLOOD PRODUCT, TREATING THE SYMPTOMS.
25
3. ACUTE HEMOLYTIC TRANSFUSION REACTION– FEVER, CHILLS, URTICARIA, DYSPNEA, CHEST PAIN,
ABDOMINAL OR LOWER BACK PAIN, TACHYCARDIA, SHOCK– LAB: ANEMIA, DIC, HEMOGLOBINEMIA, HEMOGLOBINURIA,
POSITIVE COOMBS` TEST– TREATMENT : IMMEDIATE CESSATION OF TRANSFUSION,
ADMINISTRATION OF FLUID, STEROID,MANITOL, AND MAINTAIN CARDIOVASCULAR STABILITY AND URINE OUTPUT
4. DELAYED TRANSFUSION REACTION– SYMPTOMS OCCUR IN 2-14 DAYS AFTER TRANSFUSION– UNEXPLAINED FEVER, POSITIVE DIRECT COOMBS`TEST AND
ANEMIA
26
5. ALLOIMMUNIZATION
6. GRAFT VERSUS HOST DISEASE
7. MICROBIAL CONTAMINATION1. VIRUS: - HEPATITIS B,C,D,E AND A
- HIV - EBV- HTLV I / II - HERPES VIRUS- CMV - PARVO VIRUS
2. BACTERIA : - T. PALLIDUM - M. LEPRAE - BRUCELLA ABORTUS - S. TYPHOSA - RICKETTSIA RICKETSII
3. PARACYTES- P.VIVAX, MALARIAE, FALCIPARUM,OVALE-TRYPANOSOMA CRUZI -MICROFILARIAE-AFRICAN TRYPANOSOMIASIS -T. GONDII-BABESIA MICROTI -L. DONOVANI
27
1 DIPHENHYDRAMINE
USE : TREATING PRURITUS AND RASHDOSE : 12.5-50 MG IV OVER 10-20 MIN (1 MG/KG/DOSE, MAX 50 MG)
2 EPINEPHRINE(1:1000 AQUEOUS)(1 MG/ML)
USE : SEVERE INFECTIONS: BRONCHOSPASM, HYPOTENSION, SHOCKDOSE : 0,01 ML/KG SQ (SINGLE DOSE MAX 1 MG). REPEAT Q 15 MIN X 3-4 DOSES AS NEEDED
3 EPINEPHRINE(1:200 AQUEOUS)(1,5 MG/0,3 ML)
USE : FOLLOWING STABILIZATION WITH EPINEPHRINEDOSE : 0,005 ML/KG SQ (MAX SINGLE DOSE 0,15 ML). REPEAT Q 8-12 H PRN
DRUG USED IN TREATMENT OF NON HEMOLYTIC TRANSFUSION REACTION
28
4 FLUIDS FOR HYPOTENSIVE PATIENTS, A BOLUS 20 ML/KG OF NORMAL SALINE SHOULD BE ADMINISTERED SIMOULTANEOUSLY WITH EPINEPHRINE AND STEROIDS
5 NARCOTICS USE : SPECIFIC AND EFFECTIVE TREATMENT FOR RIGORSDOSE : 0,1 MG/KG MORPHINE IV (MAX DOSE 10 MG)
6 ACETAMINOPHEN USE : TO PREVENT OR REVERSE TEMPERATURE ELEVATIONS IN MILD TO MODERATE FEBRILE REACTIONSDOSE : 10-15 MG/KG PO (MAX DOSE 800 MG)
7 STEROIDS USE : IN MODERATE TO SEVERE REACTIONS : URTICARIA, FEVER, SHAKING, CHILLS, DIAPHORESIS, OR PALLORDOSE : 1-2 MG/KG OF METHYLPREDNISOLONE (OR EQUIVALENT DOSE OF DEXAMETHASONE/ HYDROCORTISONE) IV PUSH
29
PREVENTION1. BLOOD SCREENING:
HBsAg ANTI HIV 1/2SIFILIS ANTI HCV
2. BLOOD BAG IDENTITY A. RE-TEST ABO / Rh BLOOD GROUPB. LABEL ON BLOOD BAG AND EASY TO READ, CONSISTS OF :
- NO. BLOOD BAG -BLOOD GROUP- BLOOD TYPE/ COMPONENT -SCREENING
TEST- BLOOD VOL / COMPONENT- STORED TEMP. / EXPIRED DATE